About
Dr. Grace Colón brings over 25 years of experience in biopharma, genomics, healthcare and industrial biotechnology. Her executive roles have spanned a broad range of functions in companies ranging from start-ups to publicly traded corporations. In addition to her role at InCarda, she serves on the board of directors of ProterixBio (Executive Chairman; formerly CEO), CareDx (NASDAQ:CDNA) and Cocoon Biotech, and formerly on the boards of Paradigm Diagnostics and PerceptiMed. She was also formerly a Partner and Senior Advisor at New Science Ventures, a NY-based venture capital firm with over $700M under management, and held executive and managerial roles at Intrexon Corporation, Gilead Sciences, Affymetrix, the International Genomics Consortium and McKinsey & Co. Dr. Colón received her Ph.D. from the Massachusetts Institute of Technology and a B.S. degree from the University of Pennsylvania, both in chemical engineering.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Grace
Search Investors